(firstQuint)Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines.

 This is a double-blind, randomized, parallel-group, controlled, multi-center study to evaluate the efficacy and safety of a single administration of RT001 compared to placebo applied as a bilateral application in at least 72 subjects with moderate to severe Lateral Canthal Lines.

 Subjects will be randomized within each site to 1 of 2 treatment groups in a 1:1 ratio.

 The efficacy and safety of RT001 compared to placebo will be evaluated.

 Study follow-up visits will occur at Weeks 2, 4 and 6.

.

 Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines@highlight

The purpose of this study is to evaluate the efficacy and safety of a single administration of RT001 compared to placebo gel for the treatment of moderate to severe lateral canthal lines.

